These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 29746127)

  • 21. Synthesis and Evaluation of Carbonic Anhydrase Inhibitors with Carbon Monoxide Releasing Properties for the Management of Rheumatoid Arthritis.
    Berrino E; Milazzo L; Micheli L; Vullo D; Angeli A; Bozdag M; Nocentini A; Menicatti M; Bartolucci G; di Cesare Mannelli L; Ghelardini C; Supuran CT; Carta F
    J Med Chem; 2019 Aug; 62(15):7233-7249. PubMed ID: 31287314
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and carbonic anhydrase inhibitory activities of new thienyl-substituted pyrazoline benzenesulfonamides.
    Mete E; Comez B; Inci Gul H; Gulcin I; Supuran CT
    J Enzyme Inhib Med Chem; 2016; 31(sup2):1-5. PubMed ID: 27435177
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carbonic anhydrase inhibitors. Synthesis, and molecular structure of novel series N-substituted N'-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)guanidines and their inhibition of human cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII.
    Żołnowska B; Sławiński J; Pogorzelska A; Chojnacki J; Vullo D; Supuran CT
    Eur J Med Chem; 2014 Jan; 71():135-47. PubMed ID: 24291567
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design and synthesis of novel benzenesulfonamide containing 1,2,3-triazoles as potent human carbonic anhydrase isoforms I, II, IV and IX inhibitors.
    Kumar R; Vats L; Bua S; Supuran CT; Sharma PK
    Eur J Med Chem; 2018 Jul; 155():545-551. PubMed ID: 29909339
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of 3,4-Dihydroisoquinoline-2(1H)-sulfonamides as potent carbonic anhydrase inhibitors: synthesis, biological evaluation, and enzyme--ligand X-ray studies.
    Gitto R; Agnello S; Ferro S; De Luca L; Vullo D; Brynda J; Mader P; Supuran CT; Chimirri A
    J Med Chem; 2010 Mar; 53(6):2401-8. PubMed ID: 20170095
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery of Benzenesulfonamides with Potent Human Carbonic Anhydrase Inhibitory and Effective Anticonvulsant Action: Design, Synthesis, and Pharmacological Assessment.
    Mishra CB; Kumari S; Angeli A; Monti SM; Buonanno M; Tiwari M; Supuran CT
    J Med Chem; 2017 Mar; 60(6):2456-2469. PubMed ID: 28253618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis of novel acyl selenoureido benzensulfonamides as carbonic anhydrase I, II, VII and IX inhibitors.
    Angeli A; Carta F; Bartolucci G; Supuran CT
    Bioorg Med Chem; 2017 Jul; 25(13):3567-3573. PubMed ID: 28522267
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Benzenesulfonamide bearing 1,2,4-triazole scaffolds as potent inhibitors of tumor associated carbonic anhydrase isoforms hCA IX and hCA XII.
    SitaRam ; Celik G; Khloya P; Vullo D; Supuran CT; Sharma PK
    Bioorg Med Chem; 2014 Mar; 22(6):1873-82. PubMed ID: 24560737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and carbonic anhydrase I, II, VII, and IX inhibition studies with a series of benzo[d]thiazole-5- and 6-sulfonamides.
    Abdoli M; Angeli A; Bozdag M; Carta F; Kakanejadifard A; Saeidian H; Supuran CT
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1071-1078. PubMed ID: 28753093
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 5-Substituted-benzylsulfanyl-thiophene-2-sulfonamides with effective carbonic anhydrase inhibitory activity: Solution and crystallographic investigations.
    Ivanova J; Balode A; Žalubovskis R; Leitans J; Kazaks A; Vullo D; Tars K; Supuran CT
    Bioorg Med Chem; 2017 Feb; 25(3):857-863. PubMed ID: 28024887
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Benzenesulfonamides incorporating bulky aromatic/heterocyclic tails with potent carbonic anhydrase inhibitory activity.
    Bozdag M; Alafeefy AM; Vullo D; Carta F; Dedeoglu N; Al-Tamimi AM; Al-Jaber NA; Scozzafava A; Supuran CT
    Bioorg Med Chem; 2015 Dec; 23(24):7751-64. PubMed ID: 26639945
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and carbonic anhydrase inhibition of a series of SLC-0111 analogs.
    Carta F; Vullo D; Osman SM; AlOthman Z; Supuran CT
    Bioorg Med Chem; 2017 May; 25(9):2569-2576. PubMed ID: 28347633
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carbonic anhydrase inhibitors: Design, synthesis and structural characterization of new heteroaryl-N-carbonylbenzenesulfonamides targeting druggable human carbonic anhydrase isoforms.
    Buemi MR; De Luca L; Ferro S; Bruno E; Ceruso M; Supuran CT; Pospíšilová K; Brynda J; Řezáčová P; Gitto R
    Eur J Med Chem; 2015 Sep; 102():223-32. PubMed ID: 26276436
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis of different thio-scaffolds bearing sulfonamide with subnanomolar carbonic anhydrase II and IX inhibitory properties and X-ray investigations for their inhibitory mechanism.
    Angeli A; Tanini D; Capperucci A; Malevolti G; Turco F; Ferraroni M; Supuran CT
    Bioorg Chem; 2018 Dec; 81():642-648. PubMed ID: 30253337
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Designing of novel carbonic anhydrase inhibitors and activators.
    Supuran CT; Vullo D; Manole G; Casini A; Scozzafava A
    Curr Med Chem Cardiovasc Hematol Agents; 2004 Jan; 2(1):49-68. PubMed ID: 15328829
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design and synthesis of novel 1,3-diaryltriazene-substituted sulfonamides as potent and selective carbonic anhydrase II inhibitors.
    Lolak N; Akocak S; Bua S; Koca M; Supuran CT
    Bioorg Chem; 2018 Apr; 77():542-547. PubMed ID: 29462772
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carbonic anhydrase inhibitors: Inhibition of the tumor-associated isozymes IX and XII with polyfluorinated aromatic/heterocyclic sulfonamides.
    Pastorekova S; Vullo D; Casini A; Scozzafava A; Pastorek J; Nishimori I; Supuran CT
    J Enzyme Inhib Med Chem; 2005 Jun; 20(3):211-7. PubMed ID: 16119190
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis of novel isoindoline-1,3-dione-based oximes and benzenesulfonamide hydrazones as selective inhibitors of the tumor-associated carbonic anhydrase IX.
    Abdel-Aziz AA; El-Azab AS; Abu El-Enin MA; Almehizia AA; Supuran CT; Nocentini A
    Bioorg Chem; 2018 Oct; 80():706-713. PubMed ID: 30064081
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A class of sulfonamide carbonic anhydrase inhibitors with neuropathic pain modulating effects.
    Carta F; Di Cesare Mannelli L; Pinard M; Ghelardini C; Scozzafava A; McKenna R; Supuran CT
    Bioorg Med Chem; 2015 Apr; 23(8):1828-40. PubMed ID: 25766630
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carbonic anhydrase inhibitors. Inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, IX, and XII with Schiff's bases incorporating chromone and aromatic sulfonamide moieties, and their zinc complexes.
    Puccetti L; Fasolis G; Vullo D; Chohan ZH; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2005 Jun; 15(12):3096-101. PubMed ID: 15908204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.